UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000003935
Receipt number R000004731
Scientific Title To evaluate the efficacy of XELOX+Bevacizumab for patient with Metastatic Colorectal Cancer as second-line chemotherapy
Date of disclosure of the study information 2010/08/01
Last modified on 2022/10/11 16:18:17

No. Disposal Last modified on Item of update
1 Insert 2010/07/21 17:03:44
2 Update 2012/02/01 10:18:57 Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
Email
Organization
Organization
Division name
Institute
Institute
Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2013/11/25 14:16:31 Key exclusion criteria
Key exclusion criteria
4 Update 2013/11/25 14:17:13 Email
5 Update 2015/01/21 13:15:33 Recruitment status
6 Update 2016/07/06 16:38:22 UMIN ID1
7 Update 2021/01/27 19:29:41 Recruitment status
Date of IRB
Anticipated trial start date
Last follow-up date
8 Update 2021/05/25 15:33:10 UMIN ID2
9 Update 2022/10/11 16:11:45 Recruitment status
10 Update 2022/10/11 16:13:59 Key exclusion criteria
11 Update 2022/10/11 16:18:17 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of primary person or sponsor
Organization
Organization
Organization
Address
Address
Tel
Email